
Thomas Mitard
Founder
Get their honest, personalized take on your startup.
Sign in to pitch Thomas →At a glance
- Full Name
- Thomas Mitard
- Title
- Founder and Managing Partner
- Firm
- THM Capital Advisory
- Firm Type
- Independent healthcare-focused investment banking / corporate finance advisory boutique
- Investment Stage
- Fundraising and M&A advisory for healthcare companies; verified fundraising mandates include second financing rounds, Series A, and Series B tranche financings
- Target Company Profile
- Healthcare entrepreneurs, start-ups raising capital, and established healthcare companies pursuing M&A
- Sector Focus
- Healthcare, MedTech/BioTech, digital health, healthcare services, medical-practice consolidation
- Location
- Paris, France
Background
Thomas Mitard is the founder and Managing Partner of THM Capital Advisory, an independent Paris-based advisory firm focused on healthcare corporate finance. THM lists him as Managing Partner and publishes his direct phone number, email, and LinkedIn profile on its team page.
Before founding THM, Mitard spent more than 20 years as an investor, first at Paribas, then at 3i in London and Paris, and later as a partner at Edmond de Rothschild and H.I.G. Capital. THM states that he completed around 60 transactions as an investor during that period.
Mitard founded THM Capital Advisory in 2013 and oriented the firm toward the healthcare sector from 2017. THM’s current positioning is as an independent advisory firm specialized in healthcare transactions including company sales, acquisitions, LBOs, and fundraising. The firm says it has advised roughly 30 healthcare transactions since the healthcare specialization began.
He is an ESSEC Business School graduate. THM also lists chess, jazz, and sport among his interests.
Investment Thesis & Focus
- THM’s stated focus is healthcare: the firm describes itself as “une banque d’affaires indépendante spécialisée dans la Santé.”
- The firm works with healthcare entrepreneurs across major capital events, specifically fundraising for start-ups and M&A advisory for more established businesses.
- Sector exposure shown in THM’s transaction list includes MedTech/BioTech, digital health, healthcare services, and medical-practice groups such as radiology.
- Mitard appears especially relevant for companies where healthcare domain knowledge and transaction execution both matter: THM emphasizes a combination of financial and sector expertise.
- Verified fundraising work includes private investors, family offices, business angels, and institutional funds, as shown in Womed’s €6M Series A and Plasana Medical’s €4M equity round.
- No public source reviewed verified a personal angel check size for Mitard; the public record supports healthcare fundraising and M&A advisory rather than a clearly disclosed personal angel-investing program.
Notable Investments
- Plasana Medical - MedTech company developing cold-plasma technology for chronic wound healing; THM advised its 2025 €4M equity fundraising, complemented by non-dilutive funding.
- Womed - Femtech company developing treatments for infertility and uterine pathologies; THM advised its 2023 €6M Series A with private investors and IRDI Capital Investissement.
- Priothera - Biotech company; THM lists a 2025 fundraising mandate for the first tranche of its Series B.
- Advanced Life Solutions - MedTech/BioTech company developing Perla, an organ-preservation liquid; THM advised Series A tranche financings in 2022 and 2024.
- Caerus Medical - Digital-health AI software company for lumbar-spine MRI diagnosis; THM advised shareholders on the 2025 sale to Gleamer.
- Alicante - Healthcare software company focused on medical coding and health-data value creation using AI; THM advised the 2024 sale to Ospi, controlled by Lauxera Capital Partners.
- Cutting Edge - MedTech/BioTech company designing intraocular implants for cataract treatment; THM advised a 2021 fundraising.
- Auxivia - Digital-health company; THM advised shareholders on the 2022 sale to Telegrafik.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.